The injectable drug delivery market is experiencing rapid growth, driven by rising demand for patient-friendly, sustainable, and connected devices. Prefilled syringes, pens, autoinjectors, and wearables are increasingly common, yet challenges persist in delivering large-volume or viscous biologics, ensuring safety under stricter regulations, and meeting sustainability goals. Advances such as pre-attached needles, isolation valve technologies, auto-retraction systems, and digital integration are helping to enhance usability and minimize risks.
A notable innovation is the use of novel auto-adjust plunger technology, which allows devices to automatically adapt to different fill volumes during final assembly—further boosting efficiency and improving the patient experience.
An article published in Drug Development & Delivery explores these developments in greater detail.